← Every company
Relay Therapeutics Inc SEC Filings
What Relay Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
RLAY overview →Filings on file
73
since Jun 24, 2020
Warning signs
0
none filed
Last results
Aug 6, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 6, 2026 | Results announcedMaterial agreement 8-K | Read ↗ |
| May 5, 2026 | Results announced 8-K | Read ↗ |
| Feb 26, 2026 | Results announced 8-K | Read ↗ |
| Nov 6, 2025 | Executive or director changeResults announced 8-K | Read ↗ |
| Aug 7, 2025 | Results announced 8-K | Read ↗ |
| May 5, 2025 | Results announced 8-K | Read ↗ |
| Feb 26, 2025 | Results announced 8-K | Read ↗ |
| Nov 6, 2024 | Results announced 8-K | Read ↗ |
| Aug 6, 2024 | Results announced 8-K | Read ↗ |
| May 2, 2024 | Results announced 8-K | Read ↗ |
| Feb 22, 2024 | Results announced 8-K | Read ↗ |
| Nov 2, 2023 | Results announced 8-K | Read ↗ |
| Aug 8, 2023 | Results announced 8-K | Read ↗ |
| May 4, 2023 | Results announced 8-K | Read ↗ |
| Feb 23, 2023 | Results announced 8-K | Read ↗ |
| Nov 3, 2022 | Results announced 8-K | Read ↗ |
| Aug 4, 2022 | Results announced 8-K | Read ↗ |
| May 5, 2022 | Results announced 8-K | Read ↗ |
| Feb 24, 2022 | Results announced 8-K | Read ↗ |
| Nov 10, 2021 | Results announced 8-K | Read ↗ |
| Oct 14, 2021 | Results announcedMaterial agreement 8-K | Read ↗ |
| Aug 12, 2021 | Results announced 8-K | Read ↗ |
| May 13, 2021 | Results announced 8-K | Read ↗ |
| Apr 16, 2021 | Results announcedMaterial agreementUnregistered share sale 8-K | Read ↗ |
| Mar 25, 2021 | Results announced 8-K | Read ↗ |
| Nov 12, 2020 | Results announced 8-K | Read ↗ |
| Aug 27, 2020 | Results announced 8-K | Read ↗ |
Source: Relay Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on RLAY
Company overviewEverything on RLAY in one place, with the price.Insider tradingWhat RLAY's own officers and directors buy and sell.Planned salesSales RLAY insiders have filed notice of.Executive payWhat RLAY awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in RLAY.Funds holding itWhich funds and ETFs hold RLAY, and how big a bet.PatentsWhat RLAY is filing at the patent office.